Suchergebnisse - "Challener, Douglas W"

PubPharm (17)

1

Rebound Phenomenon After Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease 2019 (COVID-19) in High-Risk Persons

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Ranganath, N. | O'Horo, J. | Challener, D. | +5

2

Curbing the Delta Surge : Clinical Outcomes After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Disease 2019

enthalten in: Mayo Clinic proceedings | 2022

von Razonable, R. | O'Horo, J. | Challener, D. | +13

3

Utility of Follow-up Coronavirus Disease 2019 (COVID-19) Antigen Tests After Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Healthcare Personnel

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Tande, A. | Swift, M. | Challener, D. | +5

4

Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019

enthalten in: Mayo Clinic proceedings | 2022

von O'Horo, J. | Challener, D. | Anderson, R. | +8

5

Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant

enthalten in: Mayo Clinic proceedings | 2022

von O'Horo, J. | Challener, D. | Speicher, L. | +10

6

Vaccination Safety : Don't Toss the Champagne With the Cork

enthalten in: Mayo Clinic proceedings | 2021

von Shah, A. | Challener, D. | O'Horo, J. | +1

7

Healthcare personnel absenteeism, presenteeism, and staffing challenges during epidemics

enthalten in: Infection control and hospital epidemiology | 2021

von Challener, D. | Breeher, L. | Frain, J. | +3

8

Association Between Chronic Statin Use and 30-Day Mortality in Hospitalized Patients With COVID-19

enthalten in: Mayo Clinic proceedings. Innovations, quality & outcomes | 2021

von Yetmar, Z. | Challener, D. | Tleyjeh, I. | +4

9

Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research

enthalten in: Mayo Clinic proceedings | 2021

von O'Horo, J. | Cerhan, J. | Cahn, E. | +75

CommentIn: Mayo Clin Proc. 2021 Apr;96(4):1092-1093. - PMID 33814077

10

Initial SARS-CoV-2 PCR crossing point does not predict hospitalization and duration of PCR positivity

enthalten in: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 2021

von Eberly, A. | Challener, D. | Shweta, F. | +5